Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Practice
100%
Obesity Management
100%
Obesity in Adolescents
100%
Efficacy Safety
100%
Semaglutide
100%
Obesity
33%
Pediatric Obesity
33%
Body Mass Index
33%
United States
16%
Long-term Safety
16%
Long-term Efficacy
16%
Hyperglycemia
16%
Pancreatitis
16%
Quality of Life
16%
Socioeconomic Disparities
16%
Randomized Clinical Trial
16%
Weight Management
16%
Subcutaneous Injection
16%
Suicidal Ideation
16%
Disordered Eating
16%
Once-weekly
16%
Anti-obesity Drugs
16%
Adolescents with Obesity
16%
Cost-effectiveness Analysis
16%
Incremental Cost-effectiveness Ratio
16%
Metabolic Parameters
16%
Alanine Aminotransferase Level
16%
Level of Life
16%
Cholelithiasis
16%
Elevated Alanine Aminotransferase
16%
Adult Studies
16%
Follow-up Duration
16%
Limited Cost
16%
Phentermine/topiramate
16%
Nursing and Health Professions
Clinical Practice
100%
Obesity Management
100%
Semaglutide
100%
Efficacy
100%
Accident Prevention
100%
Youth
100%
Body Mass
33%
Childhood Obesity
33%
Cost Effectiveness Analysis
16%
Incremental Cost-Effectiveness Ratio
16%
Metabolic Parameters
16%
Alanine Aminotransferase Level
16%
Pancreatitis
16%
Hyperlipidemia
16%
Subcutaneous Injection
16%
Weight Management
16%
Cholelithiasis
16%
Phentermine/Topiramate
16%
Hyperglycemia
16%
Quality of Life
16%
Adherence
16%
Suicidal Ideation
16%
Clinical Trial
16%
Pharmacology, Toxicology and Pharmaceutical Science
Semaglutide
100%
Childhood Obesity
33%
Randomized Clinical Trial
16%
Hyperlipidemia
16%
Pancreatitis
16%
Alanine Aminotransferase
16%
Cholelithiasis
16%
Phentermine/Topiramate
16%
Subcutaneous Injection
16%
Hyperglycemia
16%
Antiobesity
16%
Suicidal Ideation
16%